Live Breaking News & Updates on Laurence Cooper|Page 4

Stay updated with breaking news from Laurence cooper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

5 Warringtonians recognised in Queen's New Year Honours

FIVE proud Warringtonians have been recognised by The Queen in her New Year honours list for their exceptional efforts. ....

Great Sankey , United Kingdom , New South Wales , Ebrahim Adia , Jo Lappin , Laurence Cooper , Eileen Fairhurst , Susan Smith , Amanda Nicholson , Mark Thomson , Adam Hills , Stockton Heath , Kevin Mcgee , Technology Facilities Council Accelerator Science , Daresbury Laboratory , Cumbria Local Enterprise Partnership , Unemployment Benefit Office , Technology Centre , Job Centre , Technology Facilities Council , Kings Academy , Warrington Kassia Academy , Warrington Wolve Physical Disability Rugby League , Liverpool John Moores University , Oakwood Academy In Manchester , King Academy ,

'Monsieurlebun' and his gossipy Instagram glimpse into Ottawa's history

Imagine a block party where all your neighbours showed up even the ones who have been dead for a century. ....

United States , Matthew Macdougall Pyke , Anna Miriam , Blair Crawford , Laurence Cooper , Ashley Fraser Postmedia , Russell Allan , Carleton Pyke , Alexander Russell , Global Affairs Canada , Confederation Park , Ashley Fraser , Sparks Street , Newport Apartments ,

Ziopharm Oncology Inc (ZIOP) Q4 2020 Earnings Call Transcript

Ziopharm Oncology Inc (ZIOP) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Ziopharm Oncology Inc (NASDAQ: ZIOP)
Popular Searches
Operator
Greetings, and welcome to Ziopharm Oncology, Inc. Fourth Quarter and Fiscal Year 2020 Earnings Conference Call. [Operator Instructions] [Operator Instructions]
I would now like to turn the conference over to your host, Adam Levy, Executive Vice President of Investor Relations and Corporate Communications. Please go ahead.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading ....

United States , David Novak Raymond James , Chris Howerton Jefferies , Kleiner Perkins Caufield , Raymond James , Eden Biocell , James Huang , Alethia Young , Steven Rosenberg , Alethia Young Cantor Fitzgerald , Laurence James Neil Cooper , Chris Howerton , Yale Jen , Scott Kopetz , Laurence Cooper , Adam Levy , David Novak , Heidi Hagen , Raffaele Baffa , James Heidi , Deric Joseph , Ziopharm Oncology Inc , Cantor Fitzgerald , Corporate Communications , Motley Fool Ziopharm Oncology Inc , Laidlaw Co ,

Why Ziopharm Oncology Stock Is Jumping Today

Author Bio
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.
Follow @keithspeights
What happened
Shares of
Ziopharm Oncology (NASDAQ:ZIOP) were jumping 10.8% higher as of 11:55 a.m. EST on Friday. The solid gain came after the company provided its fourth-quarter update following the market close on Thursday.
Ziopharm announced a net loss in the fourth quarter of $22.8 million, or $0.11 per share. There were two bigger stories, though. The U.S. Food and Drug Administration (FDA) gave a green light for Ziopharm to begin testing its experimental T cell receptor-engineered T cell (TCR-T) therapies in phase 1/2 clinical studies. Also, Laurence Cooper is stepping down as CEO with board member Heidi Hagen taking his place as in ....

Bob Postma , Laurence Cooper , Heidi Hagen , Drug Administration , Md Anderson Cancer Center , Ziopharm Oncology , Wall Street , Cancer Center , Watermill Asset Management , பாப் பொசடமக , லாரன்ஸ் கூப்பர் , ஹெய்டி ஹேகன் , ம்ட் ஆண்டர்சன் புற்றுநோய் மையம் , சுவர் தெரு , புற்றுநோய் மையம் , வாட்டர் மில் சொத்து மேலாண்மை ,

Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors
ZIOPHARM Oncology IncFebruary 5, 2021 GMT
BOSTON, Feb. 05, 2021 (GLOBE NEWSWIRE) Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP) today announced the election of Robert Postma to its Board of Directors (the “Board”), effective immediately. Mr. Postma is the Founder of WaterMill Asset Management, a sizeable and long-term shareholder of Ziopharm.
James Huang, Chairman of the Board, said, “We welcome Bob to Ziopharm’s Board of Directors. With his experience and financial acumen, Bob will make an immediate contribution to Ziopharm and I believe the Board is now well positioned to partner with the management team to deliver on our very promising T-cell directed and cytokine technologies and opportunities.” ....

United States , Patrick Bursey , Laurence Cooper , Eden Biocell , James Huang , Robert Postma , Regeneron Pharmaceuticals , Ziopharm Oncology Inc , National Cancer Institute , Company Nasdaq , University Of Texas Md Anderson Cancer Center , Drug Administration , Exchange Commission , Lifesci Communications , Corporate Communications , Watermill Asset Management , Ziopharm Oncology , Sleeping Beauty , Cancer Center , Private Securities Litigation Reform Act , Quarterly Report , Relations Contacts , Investor Relations , Relations Contact , Sci Communications , ஒன்றுபட்டது மாநிலங்களில் ,